Sweden
· Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 34.29 billion. The enterprise value is 49.27 billion.
| Market Cap | 34.29B |
| Enterprise Value | 49.27B |
Important Dates
The next estimated earnings date is Tuesday, February 10, 2026.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Medicover AB has 151.05 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 74.43M |
| Shares Outstanding | 151.05M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 11.17% |
| Owned by Institutions (%) | 26.77% |
| Float | 50.90M |
Valuation Ratios
The trailing PE ratio is 45.91 and the forward PE ratio is 33.34. Medicover AB's PEG ratio is 0.47.
| PE Ratio | 45.91 |
| Forward PE | 33.34 |
| PS Ratio | 1.34 |
| PB Ratio | 5.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.69 |
| P/OCF Ratio | 10.08 |
| PEG Ratio | 0.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.03, with an EV/FCF ratio of 26.86.
| EV / Earnings | 66.21 |
| EV / Sales | 1.92 |
| EV / EBITDA | 13.03 |
| EV / EBIT | 27.29 |
| EV / FCF | 26.86 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 2.74.
| Current Ratio | 0.78 |
| Quick Ratio | 0.68 |
| Debt / Equity | 2.74 |
| Debt / EBITDA | 4.17 |
| Debt / FCF | 8.60 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 11.98% and return on invested capital (ROIC) is 5.63%.
| Return on Equity (ROE) | 11.98% |
| Return on Assets (ROA) | 4.64% |
| Return on Invested Capital (ROIC) | 5.63% |
| Return on Capital Employed (ROCE) | 9.41% |
| Revenue Per Employee | 546,247 |
| Profits Per Employee | 15,831 |
| Employee Count | 47,256 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 28.16 |
Taxes
In the past 12 months, Medicover AB has paid 270.87 million in taxes.
| Income Tax | 270.87M |
| Effective Tax Rate | 28.06% |
Stock Price Statistics
The stock price has increased by +24.73% in the last 52 weeks. The beta is 1.76, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | +24.73% |
| 50-Day Moving Average | 246.63 |
| 200-Day Moving Average | 241.85 |
| Relative Strength Index (RSI) | 35.24 |
| Average Volume (20 Days) | 91,747 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 25.67 billion and earned 744.05 million in profits. Earnings per share was 4.94.
| Revenue | 25.67B |
| Gross Profit | 5.91B |
| Operating Income | 1.80B |
| Pretax Income | 965.17M |
| Net Income | 744.05M |
| EBITDA | 2.74B |
| EBIT | 1.80B |
| Earnings Per Share (EPS) | 4.94 |
Balance Sheet
The company has 945.27 million in cash and 15.78 billion in debt, giving a net cash position of -14.83 billion or -98.18 per share.
| Cash & Cash Equivalents | 945.27M |
| Total Debt | 15.78B |
| Net Cash | -14.83B |
| Net Cash Per Share | -98.18 |
| Equity (Book Value) | 5.76B |
| Book Value Per Share | 37.18 |
| Working Capital | -1.48B |
Cash Flow
In the last 12 months, operating cash flow was 3.40 billion and capital expenditures -1.57 billion, giving a free cash flow of 1.83 billion.
| Operating Cash Flow | 3.40B |
| Capital Expenditures | -1.57B |
| Free Cash Flow | 1.83B |
| FCF Per Share | 12.14 |
Margins
Gross margin is 23.01%, with operating and profit margins of 7.02% and 2.90%.
| Gross Margin | 23.01% |
| Operating Margin | 7.02% |
| Pretax Margin | 3.76% |
| Profit Margin | 2.90% |
| EBITDA Margin | 10.68% |
| EBIT Margin | 7.02% |
| FCF Margin | 7.14% |
Dividends & Yields
This stock pays an annual dividend of 1.64, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | 1.64 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | 17.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 33.43% |
| Buyback Yield | -0.46% |
| Shareholder Yield | 0.25% |
| Earnings Yield | 2.17% |
| FCF Yield | 5.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.2 |
| Piotroski F-Score | 7 |